Jun Hayashi is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Apr 2010: A&G PHARMACEUTICAL INC (Columbia, MD — biotechnology — 2010; $100K reported sold to 2 investors).
What this means One deal on file with the SEC, filed Apr 2010. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Ginette Serrero (1 shared filing), Gordon Sato (1 shared filing), Jennie Mather (1 shared filing), Lars Hanan (1 shared filing), Michael Keefe (1 shared filing) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jun. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Jun Hayashi and found 1 difference: No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.